Steven Damon
Chief Executive Officer, Micron Biomedical, Inc.
Professional Overview
Steven Damon is a seasoned executive with over 30 years of experience in the biotechnology and pharmaceutical industries. As the Chief Executive Officer of Micron Biomedical, Inc., he leverages his deep expertise in business development, commercial strategy, and technology commercialization to drive the company's growth and innovation.
Experience Summary
Current Role
As the CEO of Micron Biomedical, Inc., Steven is responsible for the overall strategic direction and operational leadership of the company. Under his guidance, Micron Biomedical has successfully commercialized several novel drug delivery technologies and expanded its global footprint, positioning the company as a leader in the field of advanced drug delivery systems.
Career Progression
Prior to his current role, Steven held various senior leadership positions, including Director at Temple Therapeutics, Director and Chairman at Georgia Bio, VP of Business and Commercial Development at Femasys Inc., and SVP of Business Development at Altea Therapeutics. Throughout his career, he has demonstrated a strong track record of driving business growth, forging strategic partnerships, and advancing cutting-edge technologies.
Academic Background
Steven holds a Bachelor's degree in Business Administration from the University of Georgia, where he graduated with honors.
Areas of Expertise
- Biotechnology and pharmaceutical industry
- Business development and commercial strategy
- Technology commercialization and product launch
- Strategic partnerships and alliances
- Regulatory affairs and quality management
- Financial and operations management
Professional Impact
Under Steven's leadership, Micron Biomedical has secured several high-profile partnerships with major pharmaceutical companies, leading to the successful development and commercialization of innovative drug delivery platforms. Additionally, he has been a prominent voice in the biotechnology community, serving as the Director and Chairman of Georgia Bio, where he has actively contributed to shaping industry policies and promoting entrepreneurship.
Conclusion
With his deep industry expertise, proven track record of success, and a commitment to innovation, Steven Damon is well-positioned to continue driving Micron Biomedical's growth and cementing its position as a leading player in the advanced drug delivery market. His strategic vision and strong leadership skills make him a valuable asset to both the company and the broader biotechnology ecosystem.
